Tevogen Bio Holdings Inc.
TVGN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $151 | $1,839 | $1,240 | $476 |
| - Cash | $1 | $0 | $0 | $7 |
| + Debt | $3 | $2 | $40 | $23 |
| Enterprise Value | $153 | $1,841 | $1,279 | $493 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | -$0 | -$0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$13 | -$59 | $4 | -$15 |
| % Margin | – | – | – | – |
| Net Income | -$10 | -$60 | $4 | -$16 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.094 | -0 | 0.037 | -0.33 |
| % Growth | -23,300% | -101.1% | 111.1% | – |
| Operating Cash Flow | -$12 | -$8 | -$9 | -$5 |
| Capital Expenditures | $0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$12 | -$8 | -$9 | -$5 |